Literature DB >> 30344644

Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia.

Jennifer Westwood1, Robert Geraghty1, Patrick Jones1, Bhavan P Rai2, Bhaskar K Somani3.   

Abstract

Rezum is a minimally invasive transurethral water vapour therapy for benign prostatic enlargement which uses thermal energy for treatment. The short-term results show it to have good outcomes with a potential for outpatient-based treatment preserving sexual function. This review serves to provide an overview of the technique and evaluate its safety and efficacy.

Entities:  

Keywords:  BPH; LUTS; Prostate; Rezum; TURP; benign prostatic hyperplasia; lower urinary tract symptoms; minimally invasive surgery

Year:  2018        PMID： 30344644      PMCID： PMC6180381          DOI： 10.1177/1756287218793084

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN： 1756-2872


  19 in total

Review 1.  Current Status of Prostate Artery Embolization for Lower Urinary Tract Symptoms: Review of World Literature.

Authors:  Patrick Jones; Bhavan Prasad Rai; Rajesh Nair; Bhaskar K Somani
Journal:  Urology       Date:  2015-07-31       Impact factor: 2.649

Review 2.  Aquablation: a novel and minimally invasive surgery for benign prostate enlargement.

Authors:  Samih Taktak; Patrick Jones; Ahsanul Haq; Bhavan Prasad Rai; Bhaskar K Somani
Journal:  Ther Adv Urol       Date:  2018-02-26

3.  Three-Year Outcomes of the Prospective, Randomized Controlled Rezūm System Study: Convective Radiofrequency Thermal Therapy for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia.

Authors:  Kevin T McVary; Claus G Roehrborn
Journal:  Urology       Date:  2017-11-06       Impact factor: 2.649

4.  Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:  Kevin T McVary; Steven N Gange; Marc C Gittelman; Kenneth A Goldberg; Kalpesh Patel; Neal D Shore; Richard M Levin; Michael Rousseau; J Randolf Beahrs; Jed Kaminetsky; Barrett E Cowan; Christopher H Cantrill; Lance A Mynderse; James C Ulchaker; Thayne R Larson; Christopher M Dixon; Claus G Roehrborn
Journal:  J Urol       Date:  2015-11-22       Impact factor: 7.450

Review 5.  Medium-term Outcomes of Urolift (Minimum 12 Months Follow-up): Evidence From a Systematic Review.

Authors:  Patrick Jones; G N Rajkumar; Bhavan Prasad Rai; Omar M Aboumarzouk; Paul Cleaveland; Shalom J Srirangam; Bhaskar K Somani
Journal:  Urology       Date:  2016-05-18       Impact factor: 2.649

Review 6.  Benign prostatic hyperplasia: epidemiology, economics and evaluation.

Authors:  Camille Vuichoud; Kevin R Loughlin
Journal:  Can J Urol       Date:  2015-10       Impact factor: 1.344

7.  Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm(®) system: evaluation of acute ablative capabilities in the human prostate.

Authors:  Christopher M Dixon; Edwin Rijo Cedano; Lance A Mynderse; Thayne R Larson
Journal:  Res Rep Urol       Date:  2015-01-30

8.  Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia.

Authors:  Christopher M Dixon; Edwin Rijo Cedano; Dalibor Pacik; Vítězslav Vit; Gabriel Varga; Lennart Wagrell; Thayne R Larson; Lance A Mynderse
Journal:  Res Rep Urol       Date:  2016-11-21

9.  Perspective on the Rezūm® System: a minimally invasive treatment strategy for benign prostatic hyperplasia using convective radiofrequency water vapor thermal therapy.

Authors:  Henry H Woo; Ricardo R Gonzalez
Journal:  Med Devices (Auckl)       Date:  2017-04-27

10.  Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Micheal F Darson; Erik E Alexander; Zvi J Schiffman; Michael Lewitton; Robert A Light; Mark A Sutton; Carlos Delgado-Rodriguez; Ricardo R Gonzalez
Journal:  Res Rep Urol       Date:  2017-08-21
View more
  9 in total

Review 1.  How I Handle Retreatment of LUTS Following a Failed MIST.

Authors:  Alexis E Te; Ahra Cho; Bilal I Chughtai
Journal:  Curr Urol Rep       Date:  2021-06-11       Impact factor: 3.092

2.  Sloughing Prostatic Tissue, a Rare Complication Post Rezum Therapy: A Case Report.

Authors:  Ali Alothman; Rakan Alharbi; Ahmed Alasker; Yahya Ghazwani
Journal:  Cureus       Date:  2020-11-27

3.  Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients.

Authors:  Chen Xu; Gang Zhang; Jin-Jin Wang; Chun-Xian Zhou; Min-Jun Jiang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia.

Authors:  Guglielmo Manenti; Tommaso Perretta; Antonello Calcagni; Donatella Ferrari; Colleen P Ryan; Federico Fraioli; Rosaria Meucci; Andrea Malizia; Valerio Iacovelli; Enrico Finazzi Agrò; Roberto Floris
Journal:  Eur Radiol Exp       Date:  2021-09-17

5.  The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Authors:  Henry H Woo; Chi-Ping Huang; William J Huang; Yi-Huei Chang; Chi-Shun Lien; Archil Chkhotua; Dean S Elterman
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-05-31       Impact factor: 5.455

6.  Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities.

Authors:  Abdullah M Al Khayal; Faisal K Balaraj; Turki A Alferayan; Khalid A Alrabeeah; Saad M Abumelha
Journal:  Urol Ann       Date:  2021-03-04

Review 7.  An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy.

Authors:  Aditya Srinivasan; Run Wang
Journal:  World J Mens Health       Date:  2019-08-20       Impact factor: 5.400

8.  Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes.

Authors:  Evan B Garden; Devki Shukla; Krishna T Ravivarapu; Steven A Kaplan; Avinash K Reddy; Alexander C Small; Michael A Palese
Journal:  World J Urol       Date:  2021-01-03       Impact factor: 4.226

Review 9.  Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia.

Authors:  Patrick Jones; Giampaolo Siena; B M Zeeshan Hameed; Bhaskar K Somani
Journal:  Res Rep Urol       Date:  2021-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.